• 1 Year Returns: 12.56%
• 3 Year Returns: 24.07%
• 5 Year Returns: 15.27%

• Pharmaceuticals | 57.77%
• Labs & Life Sciences Services | 35.48%
• Fertilizers & Agro Chemicals | 3.34%
• Others | 3.20%
• Miscellaneous | 0.18%

• Sun Pharmaceutical Industries Ltd | 9.31%
• Max Healthcare Institute Ltd | 6.24%
• Abbott India Ltd | 5.98%
• Divi's Laboratories Ltd | 5.37%
• Healthcare Global Enterprises Ltd | 5.14%

• Equity | 99.07%
• Cash & Equivalents | 0.93%

The alpha ratio for the Tata India Pharma & Healthcare Fund-Reg(IDCW) is -35.82

Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

The volatility or standard deviation for the Tata India Pharma & Healthcare Fund-Reg(IDCW) is 12.59

Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

The Sharpe ratio for the Tata India Pharma & Healthcare Fund-Reg(IDCW) is 0.73

The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

The Sortino Ratio for the Tata India Pharma & Healthcare Fund-Reg(IDCW) is 0.08

The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.